In a blind race to cure HIV, can Gene therapy be a deal-breaker?
Jan 20, 2020
HIV infection has become a global health burden, has claimed over 32 million lives so far since the very first case of AIDS was reported in 1981. According to a report put ...
Read More
Malignant Pleural Mesothelioma Upcoming Therapies
Jan 15, 2020
Malignant pleural mesothelioma treatment market includes several immunotherapy agents, in the pipeline including Keytruda, Opdivo and Yervoy, which have shown promising ant...
Read More
Malignant pleural mesothelioma market: Elusive treatment approaches and Poor diagnosis
Jan 13, 2020
Malignant pleural mesothelioma (MPM) is a malignancy of pleural layers within the lung cavity and inner sides of the ribs. Year of research has revealed asbestos expo...
Read More
Anaphylaxis: A Rare Disease
Jan 10, 2020
Anaphylaxis is a rare disease which can even result in life-threatening situations. Mostly the allergic reaction is due to food, insect stings, medications and latex. ...
Read More
Egg Allergy Market: Second most common food allergy but no approved therapy
Jan 6, 2020
Hen’s egg allergy is the second most common type of allergy after cow’s milk. In infants and young children, Egg poses as one of the most vital allergens degrading the ...
Read More
Chronic Hand Eczema Market Analysis and Forecast
Eczema is an umbrella term comprising skin disorders characterised by dry, discoloured, itchy and inflamed skin. Hand eczema (HE) are non-infectious, inflammatory cutaneous...
Read More
Angelman syndrome: A Rare Genetic Disorder
Jan 1, 2020
Angelman syndrome is a rare genetic disorder, which affects the nervous system. The people who are affected by the disease, show the characteristics like intellectual disab...
Read More
Reversing Ischemia with Gene therapy
Dec 20, 2019
A human body comprises of many small, long, narrow and broad blood vessels that carry oxygenated blood from the heart to other body parts for their normal functioning. Howe...
Read More
GBT, Syros; Takeda, Cevance collaborates; IND application to ZN-c3
Dec 19, 2019
Global Therapeutics and Syros Pharmaceuticals have teamed up to move forward to discover, develop and market novel Sickle cell disease and beta-thalassemia therapies. ...
Read More
Schizophrenia vs Bipolar disorder: Biomarkers to the rescue
Dec 18, 2019
Schizophrenia and Bipolar disorder (BD) are most of the times difficult to distinguish. Schizophrenia is characterized by hallucinations, and delusions when a patient loses...
Read More
Increasing cases of Mania and Bipolar disorder market
Dec 16, 2019
Bipolar Disorder is characterized by frequent-shifts in the mood and is a manic-depressive disorder hampering the routine life of an individual. According to the American P...
Read More
Novartis buys Medicines Co. for USD 9.7 Billion
Nov 26, 2019
Novartis plans to buy The Medicines Company for USD 9.7 Billion to gain access to a heart drug inclisiran, almost ready to get into the market. Under the terms of the deal,...
Read More
GHO to advance healthcare in Europe; Truvian nets USD 27.1 Mn; Lilly plans its diabetes portfolio expansion
Nov 21, 2019
Global Healthcare Opportunities (GHO) Capital, a London-based healthcare investment firm, has recently netted USD 1.1 Billion to advance European healthcare. The company pl...
Read More
AbbVie Sells bonds to Fund Allergan takeover
Nov 14, 2019
AbbVie has traded off its bonds worth USD 30 Billion to finance the purchase of the Allergan. AbbVie this year in June has agreed to buy Allergan for USD 63 Billion,...
Read More
Non-small cell lung cancer emerging therapies
Nov 6, 2019
The Non-small cell lung cancer therapeutics market is anticipated to improve owing to better diagnostics methodologies and treatment options across the world. This would ex...
Read More
